Selecting models of nucleotide substitution: An application to human immunodeficiency virus 1 (HIV-1)

被引:122
|
作者
Posada, D [1 ]
Crandall, KA [1 ]
机构
[1] Brigham Young Univ, Dept Zool, Provo, UT 84602 USA
关键词
model selection; likelihood ratio test; Akaike information criterion; molecular clock; HIV-1;
D O I
10.1093/oxfordjournals.molbev.a003890
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The blind use of models of nucleotide substitution in evolutionary analyses is a common practice in the viral community. Typically, a simple model of evolution like the Kimura two-parameter model is used for estimating genetic distances and phylogenies, either because other authors have used it or because it is the default in various phylogenetic packages. Using two statistical approaches to model fitting, hierarchical likelihood ratio tests and the Akaike information criterion, we show that different viral data sets are better explained by different models of evolution. We demonstrate our results with the analysis of HIV-1 sequences from a hierarchy of samples; sequences within individuals, individuals within subtypes, and subtypes within groups. We also examine results for three different gene regions: gag, pol, and env. The Kimura two-parameter model was not selected as the best-fit model for any of these data sets, despite its widespread use in phylogenetic analyses of HIV-1 sequences. Furthermore, the model complexity increased with increasing sequence divergence. Finally, the molecular-clock hypothesis was rejected in most of the data sets analyzed, throwing into question clock-based estimates of divergence times for HIV-1. The importance of models in evolutionary analyses and their repercussions on the derived conclusions are discussed.
引用
收藏
页码:897 / 906
页数:10
相关论文
共 50 条
  • [1] Human immunodeficiency virus - Phylogeny and the origin of HIV-1
    Rambaut, A
    Robertson, DL
    Pybus, OG
    Peeters, M
    Holmes, EC
    NATURE, 2001, 410 (6832) : 1047 - 1048
  • [2] CONFIRMATION OF ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS (HIV-1)
    PEARSON, SD
    WITTWER, C
    ASH, KO
    CLINICAL CHEMISTRY, 1988, 34 (06) : 1181 - 1181
  • [3] HUMAN IMMUNODEFICIENCY VIRUS-TYPE-1 (HIV-1) AND THE BRAIN
    GRANT, I
    HEATON, RK
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1990, 58 (01) : 22 - 30
  • [4] HYPOCHOLESTEROLEMIA AND HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) INFECTION
    DURSUN, SM
    REVELEY, MA
    AMERICAN JOURNAL OF MEDICINE, 1995, 98 (05): : 518 - 518
  • [5] The immune response to human immunodeficiency virus type 1 (HIV-1)
    Turnbull, E
    Borrow, P
    MOLECULAR PATHOGENESIS OF VIRUS INFECTIONS, 2005, 64 : 23 - 89
  • [6] Robust growth of human immunodeficiency virus type 1 (HIV-1)
    Kim, H
    Yin, J
    BIOPHYSICAL JOURNAL, 2005, 89 (04) : 2210 - 2221
  • [7] Redox regulation of the human immunodeficiency virus type 1 (HIV-1).
    Piette, J
    Sappey, C
    Piret, B
    LegrandPoels, S
    DNA AND RNA CLEAVERS AND CHEMOTHERAPY OF CANCER AND VIRAL DISEASES, 1996, 479 : 249 - 268
  • [8] Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras
    Center, RJ
    Lebowitz, J
    Leapman, RD
    Moss, B
    JOURNAL OF VIROLOGY, 2004, 78 (05) : 2265 - 2276
  • [9] MYOPATHY WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION - HIV-1 OR ZIDOVUDINE
    TILL, M
    MACDONELL, KB
    ANNALS OF INTERNAL MEDICINE, 1990, 113 (07) : 492 - 494
  • [10] Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 gag vaccination
    Balamurugan, Arumugam
    Lewis, Martha J.
    Kitchen, Christina M. R.
    Robertson, Michael N.
    Shiver, John W.
    Daar, Eric S.
    Pitt, Jacqueline
    Ali, Ayub
    Ng, Hwee L.
    Currier, Judith S.
    Yang, Otto O.
    JOURNAL OF VIROLOGY, 2008, 82 (06) : 2784 - 2791